Influenza Clinical Trial
Official title:
Performance Feedback in Health Care
The Southeast Permanente Medical Group (TSPMG) at Kaiser Permanente Georgia provides
performance feedback to its providers. The performance feedback designs can vary and change
over time in terms of targets, summary statistics, included measures, and frequency of
delivery. The TSPMG health services research group seek to compare different performance
feedback designs to identify which are most effective at contributing to performance
improvement.
The research team will randomly assign providers into different performance feedback
conditions, as specified in the protocol. Providers will receive performance feedback through
the standard mechanism in which it is conveyed by their supervisor.
The objective is to investigate how to design performance feedback for providers to best
motivate and support them in improving performance along with existing strategic priorities
for care delivery.
The reserach team will test alternative designs of performance feedback that vary on the
following dimension:
1) targets for comparison of one's own performance
The Southeast Permanente Medical Group (TSPMG) provides performance feedback to its
providers. The performance feedback designs can vary and change over time in terms of
targets, summary statistics, included measures, and frequency of delivery. The TSPMG health
services research team will seek to compare different performance feedback designs to
identify which are most effective at contributing to performance improvement. .
The research team will randomly assign providers into different performance feedback
conditions, as specified in the protocol. Providers will receive performance feedback through
the standard mechanism in which it is conveyed by their supervisor.
The objective is to investigate how to design performance feedback for providers to best
motivate and support them in improving performance along with existing strategic priorities
for care delivery.
The research team will test alternative designs of performance feedback that vary on the
following dimension:
1) targets for comparison of one's own performance
The research team will provide feedback on performance by measures that the organization
already tracks internally and uses for performance improvement. These include a provider's
utilization of opportunities to provide flu vaccinations.
The study will randomly assign different designs of feedback to providers. In order to
understand which designs of feedback have the best effects on performance, the research team
will test the following hypotheses:
1. Displaying the next-highest quartile will motivate improvement more than display of all
quartiles.
Theory: The next-highest quartile will serve as an injunctive norm, or suggested target,
to repeatedly lift an individual's performance to the suggested level.
2. The positive effect of displaying the next-highest quartile, relative to displaying all
quartiles, will be most pronounced for initially low performers.
Theory: The next highest quartile averts upward social comparison to a much higher level
of peer performance, which can be discouraging and so negatively affect performance
3. The positive effect of displaying the next-highest quartile, relative to displaying all
quartiles, will diminish over time.
Theory: Individuals may become worn out as they see a target ratchet higher when their
performance improves.
4. Displaying team relative performance along with individual relative performance will be
more effective than displaying either type of information alone.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05523089 -
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
|
Phase 2 | |
Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
Completed |
NCT03282240 -
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
|
Phase 3 | |
Completed |
NCT00968539 -
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
Completed |
NCT00971425 -
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
|
Phase 3 | |
Completed |
NCT00968526 -
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
Completed |
NCT05525494 -
Patient Portal Flu Vaccine Reminders (5)
|
N/A | |
Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
Completed |
NCT04695717 -
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam
|
Phase 3 | |
Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
Completed |
NCT03888989 -
Response to Influenza Vaccine During Pregnancy
|
Phase 1 | |
Completed |
NCT04109222 -
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
|
Phase 4 | |
Completed |
NCT02587221 -
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
|
Phase 3 | |
Completed |
NCT03453801 -
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
|
Phase 1 | |
Completed |
NCT01440387 -
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
|
Phase 3 | |
Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
Completed |
NCT03321968 -
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
|
Phase 3 | |
Completed |
NCT00972517 -
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
|
Phase 3 | |
Completed |
NCT04570904 -
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
|
||
Recruiting |
NCT03331991 -
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
|
N/A |